Precision BioSciences Inc (DTIL)
7.32
+0.82
(+12.62%)
USD |
NASDAQ |
Nov 22, 14:44
Precision BioSciences Shareholders Equity (Quarterly): 64.87M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 64.87M |
| June 30, 2024 | 74.71M |
| March 31, 2024 | 37.21M |
| December 31, 2023 | 18.86M |
| September 30, 2023 | 29.06M |
| June 30, 2023 | 34.04M |
| March 31, 2023 | 40.18M |
| December 31, 2022 | 60.43M |
| September 30, 2022 | 84.38M |
| June 30, 2022 | 103.02M |
| March 31, 2022 | 69.66M |
| December 31, 2021 | 91.17M |
| Date | Value |
|---|---|
| September 30, 2021 | 101.44M |
| June 30, 2021 | 100.55M |
| March 31, 2021 | 58.82M |
| December 31, 2020 | 44.42M |
| September 30, 2020 | 63.82M |
| June 30, 2020 | 85.60M |
| March 31, 2020 | 115.03M |
| December 31, 2019 | 138.31M |
| September 30, 2019 | 155.79M |
| June 30, 2019 | 173.98M |
| March 31, 2019 | 10.83M |
| December 31, 2018 | 39.96M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
18.86M
Minimum
Dec 2023
138.31M
Maximum
Dec 2019
70.78M
Average
67.26M
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc | 92.29B |
| Assembly Biosciences Inc | 26.00M |
| Protagonist Therapeutics Inc | 531.92M |
| Alector Inc | 118.93M |
| Entrada Therapeutics Inc | 422.45M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 153.26M |
| Total Liabilities (Quarterly) | 88.39M |
| Debt to Equity Ratio | 0.3434 |
| Current Ratio | 9.224 |
| Net Debt Paydown Yield | 0.01% |